People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Media & Content, Other, Healthtech, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DashBid Media Inc. | — | Media & Content | Series B | $38.5M | $549.5M | 2015 |
| APJeT, Inc. | — | Other | Seed | $26.5M | $10.1M | 2011 |
| Ascellus Health, Inc. | — | Healthtech | Series A | $21.6M | $7.6M | 2025 |
| APjeT Venture LLC | — | Other | Seed | $20.4M | $7.5M | 2020 |
| EA Invesco, LLC | — | Other | Series B | $19.8M | $11.0M | 2022 |
| DashBid Venture, LLC | — | Other | Seed | $6.1M | $16.8M | 2011 |
| Centripetal Venture, LLC | — | Other | Seed | $4.0M | $4.2M | 2010 |
| IMCS Venture, LLC | — | Other | Seed | $3.5M | $13.0M | 2021 |
| eTelemetry Inc | — | Other Technology | Pre-Seed | $1.5M | $37.2M | 2009 |
| Human Connective Venture, LLC | — | Other | Pre-Seed | $1.4M | $6.7M | 2021 |
Steven Chrust at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven Chrust on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven G Chrust | 8 | 18 |
| E. Bulkeley Griswold | 8 | 17 |
| Stephen T Rossetter | 7 | 15 |
| Jeffrey I Brodlieb | 6 | 15 |
| Jeffrey Brodlieb | 5 | 5 |
| Stephen Rossetter | 4 | 5 |
| Jeffrey Isaac Brodlieb | 3 | 4 |
| Stewart I Shanley | 2 | 3 |
| Stewart T Shanley | 2 | 3 |
| David Bell | 1 | 17 |
| Jeff Williams | 1 | 13 |
| Liam Donohue | 1 | 12 |
| John White | 1 | 7 |
| KEVIN WANG | 1 | 6 |
| ALEX BLUM | 1 | 4 |
| Andrew Stein | 1 | 4 |
| Lev Volftsun | 1 | 3 |
| Thomas Herman | 1 | 3 |
| Jonathan Bloch | 1 | 3 |
| Martha Temple | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.